Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: A randomised controlled trial

Autor: Heron, Leon, Selnikova, Olga, Moiseieva, Anna, Van Damme, Pierre, van der Wielen, Marie, Levie, Karin, Hoet, Bernard, Stoffel, Michel
Zdroj: In Vaccine 2007 25(15):2817-2822
Databáze: ScienceDirect